Frances Rudnick Levin

Ball JC, and Ross A. The effectiveness of methadone maintenance treatment. 1991; New York: Springer-Verlag, 283.

Becker H.C., and Hale, R.L. Repeated Episodes of Ethanol Withdrawal Potentiate the Severity of Subsequent Withdrawal Seizures: An Animal Model of Alcohol Withdrawal "Kindling." Alcohol Clin Exp Res. 1993; 17:94-98.

Brady K., Anton R., Ballenger JC et al. Cocaine abuse among schizophrenic patients. American Journal of Psychiatry. 1990; 147:1164-1167.

Brown M.E., Anton R.F., Malcolm R., and Ballenger J.C. Alcohol Detoxification and Withdrawal Seizures: Clinical Support for a Kindling Hypothesis. Biol Psychiatry. 1988;23:507-514.

Capelhorn JRM, and Bell J. Methadone dosage and retention of patients in maintenance treatment. Medical Journal of Australia. 1991;154:195-199.

Charney DS, Sternberg DE, Kleber HD, Henninger GR, and Redmond DE. The clinical use of clonidine in abrupt withdrawal from methadone. Archives of General Psychiatry. 1981;38:1273-1277.

Chick J, Gough K, Falkowski W. Disulfiram treatment of alcoholism. Br J. Psychiatry. 1992;161:84-89.

Compton PA, Wesson DR, Charuvastra VC, Ling W. Buprenorphine as a pharmacotherapy for opiate addiction. Am J Addict. 1996;5:220-230.

Croop RS, Faulker EB, Labriola DF. The safety profile of naltrexone in the treatment of alcoholism: results from a multicenter usage study. Arch Gen Psychiatry. 1997;54:1130-1135.

Dole VP, and Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. A clinical trial with methadone hydrochloride. Journal of the American Association. 1965;193(8):646-650.

Fudala PJ, Vocci F, Montgomery A, and Trachtenberg Al. Levomethadyl acetate (LAAM) for the treatment of opioid dependence: A multisite, open-label study of LAAM safety and an evaluation of the product labeling and treatment regulations. Journal of Maintenance in the Addictions. 1997;1(2):9-39.

Fuller RK, Branchley L, Brightwell DR, et al. Disulfiram treatment of alcoholism: a Veteran's Administration cooperative study. JAMA. 1986;256:1449-1455.

Gold ME, Redmond DC, and Kleber HD. Clonidine blocks acute opiate-withdrawal symptoms. Lancet. 1978;2:599-602.

Grabowski J., Rhoades H., Schmitz J., Davis C., Creson D., and Kirby K. Fluoxetine is ineffective for treatment of cocaine dependence or concurrent opiate and cocaine dependence: Two placebo-controlled, double-blind trials. Journal of Clinical Psychopharmacology. 1995;15:163-174.

Higgins ST, Budney AJ, Bickel WK, et al. Disulfiram therapy in patients abusing cocaine and alcohol. American Journal of Psychiatry. 1993;150(4):675-676.

Himmelsbach CK. Clinical studies of drug addiction: Physical dependence, withdrawal and recovery. Archives of Internal Medicine. 1942;69:766-772.

Jasinski DR, Pevnick JS, and Griffith JD. Human pharmacology and abuse potential of the analgesic Buprenorphine. Archives of General Psychiatry. 1978;35:501-516.

Johnson RE, Fudala PJ, and Jaffe JH. A controlled trial of Buprenorphine for opioid dependence. Journal of the American Medical Association. 1992;267:2750-2755.

Kessler RC, McGonagle KA, Zhao S et tal. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry. 1994;51(1):8-19.

Kolar A., Brown B., Weddington W., Haertzen C., Michaelson B., and Jaffe J. Treatment of cocaine dependence in methadone maintenance clients: a pilot study comparing the efficacy of desipramine and amantadine. International Journal of the Addictions. 1992;27:849-868.

Kosten TR, Krystal JH, Charney DS, Price LH, Morgan CH, and Kleber, HD. Rapid detoxification from opioid dependence. American Journal of Psychiatry. 1989;146:1349.

Kosten TR, Schottenfeld R, Ziedonis D, and Falcioni J. Buprenorphine versus methadone maintenance for opioid dependence. Journal of Nervous and Mental Disease. 1993.

Kranzler HR, Burleson JA, Korner P, et al. Placebo-controlled trial of fluxotine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry. 1995;152:391-397.

Levin FR, Lehman AF. Meta-analysis of desipramine as an adjunct in the treatment of cocaine addiction. J Clin Psychopharmacol. 1991;11:374-378.

Levin FR, Evans SM, McDowell DM, and Kleber HD. Methylphenidate treatment for cocaine abusers with adult attention-deficit/hyperactivity disorder: A Pilot Study. Clin Psychiatry. 1998;56:6/June.

Ling W, Rawson RA, Compton PA. Substitution pharmacotherapies for opioid addiction: from methadone to LAAM and Buprenorphine. J Psychoactive Drugs. 1994;26(2):119-128.

Littleton J. Acamprosate in alcohol dependence: how does it work? Addiction. 1995;99:1179-1188.

Malcolm R, Ballenger JC, Sturgis ET, Anton R. Double blind controlled trial comparing carbamazepine to oxazepam treatment of alcohol withdrawal. Am J Psychiatry. 1989;146:617-621.

McLellan AT, Arndt IO, Metzger DS, Woody GE, and O'Brien CP. The effects of psychosocial services in substance abuse treatment. Journal of the American Medical Association. 1993;269(15):1953-1959.

McLellan AT, Grisson GR, Zanis D, Randall M, Brill P, and O'Brien CP. Problem-service 'matching" in addiction treatment. A prospective study in 4 programs. Archives of General Psychiatry. 1997;54(8):730-735.

Montoya ID, Levin, FR, Fudala, P, and Gorelick, DA. Double-blind comparison of carbamazepine and placebo for treatment of cocaine dependence. Drug and Alcohol Dependence. 1995;38:213-219.

O'Connor PG, Kosten TR. Rapid and ultrarapid opioid detoxification techniques. JAMA. 1998;279:229-234.

O'Malley SS, Jaffe AJ, Chang G, Schottenfeld RS, Meyer RE, Rounsaville B. Naltrexone and coping skills therapy for alcohol dependence. Arch Gen Psychiatry. 1992;49:881-887.

Payte JT. Methadone maintenance treatment: The first thirty years. Journal of Psychoactive Drugs. 1997b;29(2):149-153.

Regier DA, Farmer ME, Rae DS. Comorbidity of mental disorders with alcohol and other drug abuse. JAMA. 1990;264:2511-2518.

Rounsaville BJ, Anton SF, Carroll K, Bude D. et al. Psychiatric diagnoses of treatment-seeking cocaine abusers. Archives of General Psychiatry. 1991;48:43-51.

Sass H, Soyka M, Mann K, Zieglgansberger W. Relapse prevention by acamprosate: results from a placebo-controlled study on alcohol dependence. Arch Gen Psychiatry. 1996;53:673-680.

Senay EC. Methadone maintenance treatment. Int J Addictions. 1985;20:803-821.

Senay EC, Dorus W, Goldberg F, and Thornton W. Withdrawal from methadone maintenance. Archives of General Psychiatry. 1977;34:361-367.

Shaner A., Khalsa ME, Roberts L, Wilkins J. et al. Unrecognized cocaine use among schizophrenic patients. American Journal of Psychiatry. 1993;150:758-762.

Swift, RM. Pharmacologic treatments for drug and alcohol dependence: Experimental and standard therapies. Psychiatry Annals. 1998;28:12/December.

Sullivan J.T., M.B., Ch.B., Sykora, K., M.Sc., Schneiderman, J., Naranjo, C.A., and Sellers, E.M. Assessment of Alcohol Withdrawal: the revised clinical institute withdrawal assessment for alcohol scale (CIWA-Ar). British Journal of Addiction. 1989;84:1353-1357.

Vining E, Kosten TR, and Kleber HD. Clinical utility of rapid clonidine-naltrexone detoxification for opioid abusers. British Journal of Addiction. 1988;83:567-575.

Volpecelli JR, Alterman Al, Hayashida M, O'Brien CP. Naltrexone in the treatment of alcohol dependence. Arch Gen Psychiatry. 1992;49:876-880.